You have 9 free searches left this month | for more free features.

localized transitional cell cancer of the renal pelvis and ureter

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastro-esophageal Cancer Trial (Resistance training, Protein supplement)

Not yet recruiting
  • Gastro-esophageal Cancer
  • Resistance training
  • Protein supplement
  • (no location specified)
Dec 15, 2022

Hearing Loss, Head Neck Cancer Trial run by the National Institute on Deafness and Other Communication Disorders (NIDCD)

Not yet recruiting
  • Hearing Loss
  • Head and Neck Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Olaparib Real-world Utilization and Clinical Outcomes in France,

Active, not recruiting
  • Ovary Cancer
  • Saint Pierre, La Réunion (oversea France), France
  • +51 more
Jan 23, 2023

Lung Cancer Trial in Singapore (Low-dose CT of the Chest (LDCT) + Sampling for Biomarker Assays)

Recruiting
  • Lung Cancer
  • Low-dose CT of the Chest (LDCT) + Sampling for Biomarker Assays
  • Singapore, Singapore
  • +2 more
Feb 1, 2023

Malignant Tumors of Female Genital Organs Trial in Houston (Fulvestrant, Abemaciclib)

Active, not recruiting
  • Malignant Neoplasms of Female Genital Organs
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

CESM ABMR Breast Cancer Screening Trial

Completed
  • Breast Cancer Screening
  • Contrast-enhanced Spectral Mammography (CESM)
  • Seattle, Washington
    Seattle Cancer Care Alliance
Jan 4, 2023

Value of Ultra-fast Prostate MRI in Prostate Cancer

Not yet recruiting
  • Prostate Cancer
  • Prostate MRI
  • Zurich, ZH, Switzerland
    University Hospital Zurich
Jun 11, 2023

Magnetic Resonance Imaging in Radiotherapy for Breast Cancer

Recruiting
  • Breast Cancer
  • Magnetic Resonance Imaging Simulation
  • San Francisco, California
    University of California, San Francisco
Jun 5, 2023

gastRic Cancer patIentS Undergoing Multimodal trEatment

Recruiting
  • Gastric Cancer
  • +3 more
  • Observational Survey
  • Lublin, Poland
    Medical University of Lublin
Feb 9, 2023

Cytomegalovirus Infections, Primary Immune Deficiency Disorder Trial in United States (viral specific cytotoxic t-lymphocytes)

Recruiting
  • Cytomegalovirus Infections
  • Primary Immune Deficiency Disorder
  • viral specific cytotoxic t-lymphocytes
  • Los Angeles, California
  • +7 more
Sep 27, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +2 more
  • Questionnaire Administration
  • Tonation Breathing Technique
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Myelofibrosis Trial in Belgium, Netherlands (Pacritinib)

Active, not recruiting
  • Myelofibrosis
  • Antwerpen, Belgium
  • +11 more
Aug 19, 2022

COVID-19, End Stage Renal Disease Trial in Copenhagen, Herlev, Hillerød (Hydroxychloroquine)

Withdrawn
  • COVID-19
  • End Stage Renal Disease
  • Copenhagen, Denmark
  • +2 more
Nov 5, 2021

Head Neck Cancer, Oropharynx Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Columbia (Cisplatin injection)

Recruiting
  • Cancer of the Head and Neck
  • +3 more
  • Cisplatin injection
  • Columbia, Missouri
    University of Missouri
Oct 31, 2022

Lymphoma Trial in New York (rituximab, bendamustine, melphalan)

Active, not recruiting
  • Lymphoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 10, 2023

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 15, 2021

Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)

Not yet recruiting
  • Venous Thromboembolism
  • Urologic Cancer
  • Rivaroxaban 10 MG
  • Placebo control
  • (no location specified)
Jun 16, 2023

Norris ORIEN Total Cancer Care

Recruiting
  • Cancer Risk
  • Malignant Neoplasm
  • Biospecimen Collection
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 19, 2022

The RISC Registry--Risk Informed Screening Registry

Not yet recruiting
  • Breast Cancer Risk
  • Cancer Risk Screening and Follow up
  • Palo Alto, California
    PHEI--Precision Health Equity Initiative
Apr 28, 2023

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Recruiting
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +9 more
  • Duarte, California
    City of Hope Medical Center
May 19, 2022

CDH1 Germline Mutations in Lobular Breast Cancer

Active, not recruiting
  • Lobular Breast Carcinoma
  • CDH1 Gene Inactivation
    • Milan, Italy
      European Institute of Oncology
    Jan 11, 2022

    Leukemia Trial (Prehabilitation)

    Not yet recruiting
    • Leukemia
    • Prehabilitation
    • (no location specified)
    Dec 5, 2022

    Colorectal Surgery, Geriatric Assessment, Quality of Life Trial in Brussels, Jette (Geriatric Assessment)

    Recruiting
    • Colorectal Surgery
    • +2 more
    • Geriatric Assessment
    • Brussels, Belgium
    • +1 more
    Apr 28, 2023

    NSCLC/Oligometastatic Cancer (Single Lung Lesion) Trial in Dublin (Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR))

    Recruiting
    • NSCLC/Oligometastatic Cancer (Single Lung Lesion)
    • Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR)
    • Dublin, Ireland
    • +1 more
    Feb 11, 2022

    Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)

    Withdrawn
    • Leukemia
    • Stem Cell Transplantation
    • Munich, Bavaria, Germany
      3. Medizinische Klinik, Klinikum rechts der Isar der TU München
    Dec 5, 2022